✦ LIBER ✦

Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan

✍ Scribed by Kensei Tobinai

Publisher: Springer
Year: 2001
Tongue: English
Weight: 130 KB
Volume: 48
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800100313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of B-cell non-Hodgkin's lympho

Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab

✍ Stefano Sacchi; Massimo Federico; Giuseppe Dastoli; Claudia Fiorani; Giovanni Vi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are probably due to complement and antibody-dependent cell-mediated cytotoxicity, and induction of apoptosis. Phase II trials have

Monoclonal Antibody Therapy for B-Cell L

Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Successful Treatment With a Chimeric Ant

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

✍ Takahiro Maeda; Yasuaki Yamada; Masayuki Tawara; Reishi Yamasaki; Yuichi Yakata; 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 188 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

Chimeric anti-CD20 monoclonal antibody (

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial – Intergroup Collaborative Study

✍ M. van Oers; A. Hagenbeek; M. Van Glabbeke; I. Teodorovic 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 141 KB

Quality of life during maintenance thera

Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin’s lymphoma: results of a prospective randomized controlled trial

✍ Mathias Witzens-Harig; Monika Reiz; Christiane Heiß; Axel Benner; Manfred Hensel 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 139 KB